secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silence Therapeutics plc (SLN)
CIK:        0001479615
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001193125-25-113364
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silence Therapeutics appoints Tim McInerney to board; James Ede-Golightly to retire at June 2025 AGM
--------------------------------------------------------------------------------

- Tim McInerney appointed director effective May 5, 2025; will chair Remuneration Committee and join Audit and Risk Committee.
- James Ede-Golightly to retire at end of his term at 2025 AGM (June 26); steps down as Remuneration Committee chair immediately.
- McInerney receives $56,000 annual retainer, initial option for 48,000 ordinary shares (36-month monthly vest), and annual grant of same.
- McInerney brings 30+ years pharma/healthcare investment banking and executive experience; served on boards of Emisphere, Insite Vision, etc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479615/000119312525113364/0001193125-25-113364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479615/000119312525113364/d70963d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-113364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer